Search clinical trials for: ARGOS-IO system

Total 78544 results

Implandata Ophthalmic Products GmbH

Completed

Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation

Congenital Glaucoma | Stevens-Johnson Syndrome | Graft vs Host Disease | Congenital Aniridia | Chemical Burns

Germany
Implandata Ophthalmic Products GmbH

Completed

Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG)

Primary Open Angle Glaucoma (POAG)

Germany
Implandata Ophthalmic Products GmbH

Completed

Long-term Safety and Performance of the ARGOS-IO Intraocular Pressure Sensor System in Subjects With Primary Open Angle Glaucoma (POAG)

Primary Open-angle Glaucoma

Germany
WellSpan Health
University of Pennsylvania

Completed

Intraosseous Access in the Emergency Department for Patients With Failed Attempts at Intravenous Access: A Randomized Trial Examining Resource Utilization and Patient Satisfaction

Difficult Peripheral IV Access

United States
Second Affiliated Hospital, School of Medicine,...
The First Affiliated Hospital with Nanjing Medical University; Shanghai Zhongshan... and other collaborators

Recruiting

Intraosseous Versus Intravenous Vascular Access During Resuscitation Following Out-of-Hospital Cardiac Arrest

Out-of-Hospital Cardiac Arrest

China
Binx Health Limited

Completed

Evaluation of the Atlas Genetics io® CTNG System (IO-CTNG)

Gonorrhea | Chlamydia Trachomatis

United States
Baxano Surgical, Inc.

Unknown

The iO-Flex® Study: Evaluation of the Baxano iO-Flex® System for Decompressive Lumbar Surgery

Lumbar Spinal Stenosis

United States
Sultan Qaboos University
Christian Medical College, Vellore, India

Unknown

Symmetrical Versus Asymmetrical Surgery for Asymmetrical Inferior Oblique Overaction

Strabismus

Oman
Vidacare Corporation

Completed

Healthy Adult Volunteer Study of Intraosseous Infusion Using the Sternum

Intraosseous Vascular Access

United States
Vidacare Corporation

Completed

Follow-Up Study Validating a Blended Technique

Intraosseous Vascular Access

United States
Baxano Surgical, Inc.

Unknown

Spondylolisthesis Treated With an iO-Flex® System Enabled Decompression (STRiDE)

Radiculopathy | Lumbar Spinal Stenosis | Spondylolisthesis

United States
Vidacare Corporation

Completed

Observation of Intraosseous Vascular Access in the Emergency Department

Patients Requiring Urgent Vascular Access

United States
Wake Forest University Health Sciences

Completed

Intraosseous Versus Intravenous Vascular Access During Cardiac Arrest

Cardiac Arrest

United States
Vidacare Corporation

Completed

Continuous Intraosseous Vascular Access Over 48 Hours

Intraosseous Vascular Access

United States
Zimmer Biomet

Completed

Arcos Revision Stem: Evaluation of Clinical Performance

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Fracture | Complications; Arthroplasty | Deformity

Finland, Sweden, Spain, United Kingdom
Immune-Onc Therapeutics
California Institute for Regenerative Medicine (CIRM)

Recruiting

IO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMML

CMML | AML With Monocytic Differentiation

United States
PainQx, Inc
National Institute on Drug Abuse (NIDA)

Completed

Expanded Development of a Medical Device Utilizing an EEG-Based Algorithm for the Objective Quantification of Pain

Chronic Pain

United States
PulseMedica

Completed

Real-time Eye Tracking and Imaging of the Eye in Diabetic Retinopathy Patients

Diabetic Retinopathy | Retinal Imaging

Canada
Immune-Onc Therapeutics
Regeneron Pharmaceuticals

Completed

First-in-human Study of IO-108 as Single Agent and in Combination With a PD-1 Immune Check Point Inhibitor in Patients With Advanced Solid Tumors

Solid Tumor, Adult

United States
Eye & ENT Hospital of Fudan University
Shandong Provincial Hospital; Children's Hospital of Fudan University; Xinhua... and other collaborators

Recruiting

IOBT Versus IO-Rec for Hypertropia With IOOA (IIHIOOA)

Hypertropia | Inferior Oblique Overaction

China
Salus University

Terminated

Regimens of Intermittent Occlusion Therapy for Amblyopia in Children

Amblyopia

United States
Immune-Onc Therapeutics

Completed

Dose Confirmation and Dose Expansion Phase 1 Study of IO-108 and IO-108 + Anti-PD-1 in Solid Tumors

Advanced Solid Tumor

China
Shammas Eye Medical Center
Sengi

Recruiting

Accuracy of the New Barrett TAL Formula With the Argos Measurements: A Multicenter Prospective Study

Cataract

United States
Seoul National University Hospital
Seoul National University Bundang Hospital; SMG-SNU Boramae Medical Center; Ewha...

Unknown

VolumE maNagement Under Body Composition Monitoring in Critically Ill patientS on CRRT

Fluid Overload | Renal Dialysis

Korea, Republic of
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Peking University

Completed

Study of KN026 Combined With KN046 in Patients With Locally Advanced HER2-positive Solid Tumors

HER2-positive Solid Tumors

China
Salus University
Indiana University

Terminated

Efficacy of Intermittent Occlusion Therapy Glasses for Amblyopia

Amblyopia

United States
Vidacare Corporation

Unknown

Infusion Flow Rates and Blood Sampling

Intraosseous Access | Infusion Rates | Intraosseous Blood | Venous Blood

United States
Rutgers, The State University of New Jersey

Completed

Intraosseous Catheter Confirmation Study

Critical Illness

United States
Immune-Onc Therapeutics

Completed

Dose-Escalation and Dose-Expansion Study of IO-202 and IO-202+Pembrolizumab in Solid Tumors

Solid Tumor, Adult

United States
Multack Eye Care

Completed

Randomized Trial Comparing Prediction Accuracy of Two Swept Source Optical Coherence Tomography Biometers

Cataract

United States
Lazarski University
Poznan University of Medical Sciences; Wroclaw Medical University; Medical University...

Completed

Intravascular Access of COVID-19 Patient Under Personal Protective Equipment

Emergencies | Cardiac Arrest

Poland
Second Sight Medical Products

Completed

Post-Market Study of the Argus® II Retinal Prosthesis System - France

Retinitis Pigmentosa

France
University of Roehampton

Recruiting

The Effects of io Fibrewater Supplementation on Gut Health, Immunity and Metabolism in Overweight Adults (IOFW)

Healthy

United Kingdom
Istituto Clinico Humanitas

Recruiting

Efficacy and Safety of HYbrid Argon Plasma Coagulation Technique in Patients With Barrett's Esophagus-Related Dysplasia (HYBRID)

Barrett's Esophagus

Italy
Haukeland University Hospital
Ministry of Defence, Norway

Completed

Sternal Intraosseous Transfusion of Autologous Whole Blood: A Comparison of Flow Rates and Degree of Hemolysis

Hemorrhagic Shock | Hypovolemic Shock

Norway
Universitaire Ziekenhuizen KU Leuven

Active, not recruiting

Foot and Ankle Arthrodesis or Osteotomy With Io-Fix Type Fixation

Foot and Ankle Arthrodesis | Foot and Ankle Osteotomy

Belgium
Second Sight Medical Products

Completed

Feasibility Study of a Chronic Retinal Stimulator in Retinitis Pigmentosa ((A16))

Retinitis Pigmentosa

United States
Implandata Ophthalmic Products GmbH
CRO Dr. med. Kottmann GmbH & Co. KG

Completed

Performance and Safety of the ARGOS-SC01 Suprachoroidal Pressure Sensor in Patients With Glaucoma Undergoing Non-penetrating Glaucoma Surgery (ARGOS-SC01)

Glaucoma | Open Angle Glaucoma

Germany, Switzerland
Vidacare Corporation

Terminated

Observational Study of CT Dye Administration Through the Intraosseous Vascular Access Route

Intraosseous Vascular Access Patients Requiring CT Exam

United States
HealthPartners Institute
Vidacare Corporation

Completed

Intraosseous Pressure Monitoring in Intensive Care Unit Patients

Blood Pressure

United States
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgey and NK Immunotherapy for Recurrent Ovarian Cancer

Recurrent Ovarian Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer

Recurrent Tongue Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer

Recurrent Laryngeal Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical Cancer

Recurrent Cervical Cancer

China
UNICANCER

Recruiting

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients With Metastatic Cancer in Response After 6 Months of Standard IO (MOIO)

Melanoma | Renal Cell Carcinoma | Head and Neck Cancer | Hepatocellular Carcinoma | Lung Cancer Metastatic | Bladder Cancer | Triple Negative Breast Cancer | Merkel Cell Carcinoma

France
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgey and NK Immunotherapy for Recurrent Pharyngeal Cancer

Recurrent Pharyngeal Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgery and NK Immunotherapy for Recurrent Sarcoma

Recurrent Adult Soft Tissue Sarcoma

China
Implandata Ophthalmic Products GmbH
CRO Dr. med. Kottmann GmbH & Co. KG

Active, not recruiting

Long-term Safety and Performance of the ARGOS-SC Suprachoroidal Pressure Sensor System in Patients With Glaucoma Underwent Non-penetrating Glaucoma Surgery

Glaucoma | Open Angle Glaucoma

Germany, Switzerland
National Eye Institute (NEI)

Completed

Branch Vein Occlusion Study

Macular Degeneration | Vitreous Hemorrhage | Neovascularization, Pathologic
Vidacare Corporation

Completed

Proximal Humerus Site for Anesthesia

Intraosseous Vascular Access

United States

Search clinical trials for: ARGOS-IO system

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Oman

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations